Skip to content

Clinical Study Of unani formulation and betamethsone in the treatment of Psoriasis.

Clinical study of Taqashshur-al-jild (psoriasis) with Therapeutic evaluation of Unani drugs Aftimoon (Cuscuta reflexa) with Ma ul Jubn (whey) as Joshanda (Decoction) and Magh Tukhmi Kharpaza (seed of kernel of musk melon) along with Gule Baboona (Matriucccaria chamomillia) as Zimad (paste) in its Management

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026420
Enrollment
52
Registered
2020-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

Intervention1: decoction of aftimoon 5gm morninig and 5gm evevning with Ma ul jbn 170 ml morning and evening and locally paste of magz tukhm kharpaza and gule baboona in equal quantity.: Mode Of appli

Sponsors

central counsal for research in unani medicine new delhi
Lead Sponsor
Regional Research Institute Of Unani Medicine Naseem Bagh Campus University Of Kashmir Srinagar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Clinically Diagnosed Patients of Psoriasis. Patients irrespective of gender. Patients in the age group of 10-60 years. Clinically stable patients. Patients who have agreed to sign the informed consent form and follow up the protocol.

Exclusion criteria

Exclusion criteria: Subjects below the age group of 10 and above the age of 60 years. Patients suffering from from other concomitant disorders like Dermatophytes,Eczema ,Seborrhic Dermatitis,Pityriasis Rosea. Patients with systemic diseases like diabetes,malignancy. patients who refuse to give written consent for the study. pregnant and lactating women. any of them not covered under inclusion criteria.

Design outcomes

Primary

MeasureTime frame
relief in signs and symptoms of psoriasisTimepoint: 6-12 Weeks.

Secondary

MeasureTime frame
not applicableTimepoint: not applicable

Countries

India

Contacts

Public ContactDr Towseef Amin Rafeeqi

Regional Research Institute of Unani Medicine

naquibislam@gmail.com9469154930

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026